Samsung Organoids: Organoid-Based Drug Screening Services

When selecting an organoid testing partner, reliability, high-quality data, and flexible study design are essential to ensuring meaningful and actionable outcomes. Samsung Biologics provides advanced patient-derived organoids (PDOs) that closely mimic human physiology, delivering clinically relevant insights to support informed decision-making in the early stages of drug development.

Our robust, validated workflows and customizable assay panels enable precise evaluation of drug efficacy, toxicity, and mechanism of action, helping to de-risk programs early, reduce overall development costs, and streamline the path toward IND submission. With a focus on scientific rigor and adaptability, our organoid solutions empower researchers to optimize candidate selection and accelerate development timelines.